These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16179569)

  • 1. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.
    Bocti C; Swartz RH; Gao FQ; Sahlas DJ; Behl P; Black SE
    Stroke; 2005 Oct; 36(10):2126-31. PubMed ID: 16179569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ischemic cholinergic damage on cognition in patients with subcortical vascular cognitive impairment.
    Kim SH; Kang HS; Kim HJ; Moon Y; Ryu HJ; Kim MY; Han SH
    J Geriatr Psychiatry Neurol; 2012 Jun; 25(2):122-7. PubMed ID: 22689705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
    Behl P; Bocti C; Swartz RH; Gao F; Sahlas DJ; Lanctot KL; Streiner DL; Black SE
    Arch Neurol; 2007 Feb; 64(2):266-72. PubMed ID: 17296844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study.
    Gouw AA; Van der Flier WM; van Straaten EC; Barkhof F; Ferro JM; Baezner H; Pantoni L; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Fazekas F; Scheltens P;
    J Neurol; 2006 Sep; 253(9):1189-96. PubMed ID: 16998647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.
    van der Flier WM; van Straaten EC; Barkhof F; Verdelho A; Madureira S; Pantoni L; Inzitari D; Erkinjuntti T; Crisby M; Waldemar G; Schmidt R; Fazekas F; Scheltens P
    Stroke; 2005 Oct; 36(10):2116-20. PubMed ID: 16141425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study.
    Kim S; Choi SH; Lee YM; Kim MJ; Kim YD; Kim JY; Park JH; Myung W; Na HR; Han HJ; Shim YS; Kim JH; Yoon SJ; Kim SY; Kim DK
    Int Psychogeriatr; 2015 Dec; 27(12):2069-77. PubMed ID: 26212042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
    Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
    Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cholinergic pathway disruption on cortical and subcortical volumes in subcortical vascular cognitive impairment.
    Lim JS; Kwon HM; Lee YS
    Eur J Neurol; 2020 Jan; 27(1):210-212. PubMed ID: 31444924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cholinergic pathway involvement in Alzheimer's disease and subcortical ischemic vascular dementia.
    Kim HJ; Moon WJ; Han SH
    J Alzheimers Dis; 2013; 35(1):129-36. PubMed ID: 23364137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.
    Ylikoski R; Jokinen H; Andersen P; Salonen O; Madureira S; Ferro J; Barkhof F; van der Flier W; Schmidt R; Fazekas F; Scheltens P; Waldemar G; Salvadori E; Pantoni L; Inzitari D; Erkinjuntti T;
    Dement Geriatr Cogn Disord; 2007; 24(2):73-81. PubMed ID: 17565216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-associated leukoaraiosis and cortical cholinergic deafferentation.
    Bohnen NI; Müller ML; Kuwabara H; Constantine GM; Studenski SA
    Neurology; 2009 Apr; 72(16):1411-6. PubMed ID: 19380700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.
    van Straaten EC; Fazekas F; Rostrup E; Scheltens P; Schmidt R; Pantoni L; Inzitari D; Waldemar G; Erkinjuntti T; Mäntylä R; Wahlund LO; Barkhof F;
    Stroke; 2006 Mar; 37(3):836-40. PubMed ID: 16439704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual rating of white matter hyperintensities in Parkinson's disease.
    Beyer MK; Aarsland D; Greve OJ; Larsen JP
    Mov Disord; 2006 Feb; 21(2):223-9. PubMed ID: 16161159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma.
    Yüksel N; Anik Y; Altintaş O; Onur I; Cağlar Y; Demirci A
    Ophthalmologica; 2006; 220(2):125-30. PubMed ID: 16491036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural and psychological symptoms are not related to white matter hyperintensities and medial temporal lobe atrophy in Alzheimer's disease.
    Staekenborg SS; Gillissen F; Romkes R; Pijnenburg YA; Barkhof F; Scheltens P; van der Flier WM
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):387-92. PubMed ID: 17907266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders.
    Kim YE; Lim JS; Suh CH; Heo H; Roh JH; Cheong EN; Lee Y; Kim JW; Lee JH
    Alzheimers Res Ther; 2024 Aug; 16(1):185. PubMed ID: 39148136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new classification system for ischemia using a combination of deep and periventricular white matter hyperintensities.
    Noh Y; Lee Y; Seo SW; Jeong JH; Choi SH; Back JH; Woo SY; Kim GH; Shin JS; Kim CH; Cho H; Park JS; Lee JM; Hong CH; Kim SY; Lee JH; Kim SY; Park KH; Han SH; Cheong HK; Na DL
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):636-42. PubMed ID: 23867045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.